University of Huddersfield (The) and GSK plc KTP 22_23 R2
Lead Participant:
THE UNIVERSITY OF HUDDERSFIELD
Abstract
To investigate, establish and embed ultraviolet dissolution imaging technology, to drive significant improvements in pharmaceutical oral product development and manufacture. Benefits include earlier risk assessment, enhanced processes, and increased profitability through substantial cost reduction.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| THE UNIVERSITY OF HUDDERSFIELD | £181,071 | £ 90,536 |
Participant |
||
| GLAXOSMITHKLINE PLC | ||
| INNOVATE UK |
People |
ORCID iD |